ACADIA Pharmaceuticals Ownership | Who Owns ACADIA Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

ACADIA Pharmaceuticals Ownership Summary


ACADIA Pharmaceuticals is owned by 14.26% institutional investors, 0.54% insiders, and 85.20% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 25.56% of ACAD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.37% of its assets in ACADIA Pharmaceuticals shares.

ACAD Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockACADIA Pharmaceuticals14.26%0.54%85.20%
SectorHealthcare Stocks 232.52%10.72%-143.24%
IndustryBiotech Stocks 384.56%10.59%-295.14%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp42.90M25.56%$915.42M
Blackrock funding, inc. /de20.76M12.29%$554.38M
Vanguard group15.15M8.98%$404.76M
Blackrock12.06M7.32%$196.01M
State street7.26M4.32%$154.83M
Rtw investments, lp7.14M4.26%$152.46M
D. e. shaw3.24M1.95%$59.48M
Geode capital management3.24M1.92%$86.54M
Dimensional fund advisors lp2.92M1.73%$78.02M
Adage capital partners gp2.48M1.48%$53.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Palo alto investors lp2.47M9.74%$52.64M
Baker bros. advisors lp42.90M6.61%$915.42M
Nan fung group102.98K3.69%$2.20M
Stonepine capital management174.54K3.03%$3.72M
Birchview capital, lp171.00K2.76%$3.65M
Axecap investments136.68K2.25%$3.65M
Rtw investments, lp7.14M1.88%$152.46M
Braidwell lp2.38M1.51%$50.76M
Tang capital management1.50M1.23%$32.01M
Hussman strategic advisors147.00K0.95%$3.93M

Top Buyers

HolderShares% AssetsChange
Braidwell lp2.38M1.51%2.38M
Adage capital partners gp2.48M0.08%1.88M
Norges bank1.51M0.00%1.51M
Jacobs levy equity management1.36M0.09%1.36M
Arrowstreet capital, limited partnership1.65M0.02%1.31M

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp7.14M1.88%-1.85M
Point72 asset management1.49M0.05%-1.69M
Citigroup83.68K0.00%-1.49M
Ecor1 capital---1.35M
American century companies418.30K0.00%-1.15M

New Positions

HolderShares% AssetsChangeValue
Braidwell lp2.38M1.51%2.38M$50.76M
Norges bank1.51M0.00%1.51M$40.27M
Eversept partners, lp164.24K0.24%164.24K$3.50M
Bridgewater associates, lp163.25K0.01%163.25K$3.48M
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main71.04K0.00%71.04K$1.52M

Sold Out

HolderChange
Coppell advisory solutions-4.00
Bear mountain capital-7.00
Financial consulate-10.00
Concord wealth partners-10.00
Advisornet financial-12.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025107-69.69%24,070,676-85.64%140.14%52-72.92%38-64.15%
Sep 30, 2025134-59.02%29,202,139-82.81%170.17%67-54.73%41-66.94%
Jun 30, 2025321-3.02%169,479,977-1.03%1000.96%143-12.80%12318.27%
Mar 31, 20253298.94%171,281,5815.19%1021.07%163-8.94%10341.10%
Dec 31, 20242949.70%162,117,2274.78%971.12%17134.65%74-7.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF7.37M4.37%-
Vanguard Total Stock Mkt Idx Inv3.94M2.34%-84.41K
Vanguard US Total Market Shares ETF3.89M2.33%4.42K
Vanguard Small Cap Index3.05M1.81%-19.99K
iShares Russell 2000 ETF3.01M1.78%-
Vanguard Small Cap Growth Index Inv1.72M1.02%-638.00
First Trust NYSE Arca Biotech ETF1.62M0.96%-
SPDR® S&P Biotech ETF1.54M0.91%3.42K
Vanguard Institutional Extnd Mkt Idx Tr1.33M0.79%-579.67K
Fidelity Small Cap Index1.25M0.74%35.09K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 09, 2026Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SECSell$162.49K
Nov 18, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$243.11K
Nov 18, 2025Kihara James PRINCIPAL ACCOUNTING OFFICERSell$96.75K
Nov 10, 2025Daly James M-Sell$670.98K
Sep 15, 2025Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICERSell$82.73K

Insider Transactions Trends


DateBuySell
2026 Q1-1
2025 Q4-3
2025 Q3-3
2025 Q2-8
2025 Q1-5

ACAD Ownership FAQ


Who Owns ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals shareholders are primarily institutional investors at 14.26%, followed by 0.54% insiders and 85.20% retail investors. The average institutional ownership in ACADIA Pharmaceuticals's industry, Biotech Stocks , is 384.56%, which ACADIA Pharmaceuticals falls below.

Who owns the most shares of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals’s largest shareholders are Baker bros. advisors lp (42.9M shares, 25.56%), Blackrock funding, inc. /de (20.76M shares, 12.29%), and Vanguard group (15.15M shares, 8.98%). Together, they hold 46.83% of ACADIA Pharmaceuticals’s total shares outstanding.

Does Blackrock own ACADIA Pharmaceuticals?

Yes, BlackRock owns 7.32% of ACADIA Pharmaceuticals, totaling 12.06M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 196.01M$. In the last quarter, BlackRock increased its holdings by 393.47K shares, a 3.37% change.

Who is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Palo alto investors lp is ACADIA Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 9.74% of its assets in 2.47M ACADIA Pharmaceuticals shares, valued at 52.64M$.

Who is the top mutual fund holder of ACADIA Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ACADIA Pharmaceuticals shares, with 4.37% of its total shares outstanding invested in 7.37M ACADIA Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools